FDA clears Interventional Spine's new lordotic intervertebral body fusion device: 4 things to know

Spinal Tech

The FDA cleared Interventional Spine's 80 Lumbar Lordotic Opticage Expandable Intervertebral Body Fusion Device.

Here are four things to know:


1. The lumbar intervertebral body fusion device is indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2-S1.


2. Surgeons can implant the device via posterior, transforaminal or lateral approach. It also aims to provide for optimum graft injection through its patented delivery system.


3. The device joins the Interventional Spine family of Opticage Expandable Interbody Fusion Devices, which received FDA clearance late last year.


4. Interventional Spine is currently in the process of assessing other sizes and configurations for its line of Lordotic Expandable Opticages.


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers